About Us > Investors
Acacia Pharma is backed by Gilde Healthcare Partners, Lundbeckfond Ventures, management and private investors.
Gilde Healthcare Partners a transatlantic venture and growth capital firm, is headquartered in Utrecht, the Netherlands. It has over €400 million under management and is actively looking to lead new investments in therapeutics, diagnostics, medical devices and enabling technologies. Gilde can invest up to €15 million in a company. Gilde is a successful builder of healthcare businesses across Europe. By investing in companies with clear achievable business models, Gilde has used its financial resources and network to create significant value for both its investors and the entrepreneurs it backs. For a list of Gilde’s portfolio companies please visit the website.
Lundbeckfond Ventures is an open and evergreen life science venture fund investing in companies primarily in Europe, but selectively also in the US. It is financially driven and invests in late stage drug discovery and development, as well as in medtech and diagnostics. Lundbeckfond Ventures is part of the asset management subsidiary of the Lundbeck Foundation which in addition to substantial financial assets has majority or significant ownerships in H. Lundbeck A/S, ALK-Abelló A/S and Falk A/S. www.lundbeckfondventures.dk